NOVONIX LTD-ADR (NVX) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:NVX • US67010L1008

0.93 USD
-0.01 (-1.59%)
At close: Feb 11, 2026
0.93 USD
0 (0%)
After Hours: 2/11/2026, 4:30:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall NVX gets a fundamental rating of 2 out of 10. We evaluated NVX against 123 industry peers in the Electronic Equipment, Instruments & Components industry. NVX has a bad profitability rating. Also its financial health evaluation is rather negative. NVX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year NVX has reported negative net income.
  • NVX had a negative operating cash flow in the past year.
  • In the past 5 years NVX always reported negative net income.
  • NVX had a negative operating cash flow in each of the past 5 years.
NVX Yearly Net Income VS EBIT VS OCF VS FCFNVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -27.71%, NVX is doing worse than 73.98% of the companies in the same industry.
  • The Return On Equity of NVX (-46.06%) is worse than 74.80% of its industry peers.
Industry RankSector Rank
ROA -27.71%
ROE -46.06%
ROIC N/A
ROA(3y)-22.59%
ROA(5y)-20.43%
ROE(3y)-33.39%
ROE(5y)-27.76%
ROIC(3y)N/A
ROIC(5y)N/A
NVX Yearly ROA, ROE, ROICNVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

  • NVX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NVX Yearly Profit, Operating, Gross MarginsNVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • NVX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, NVX has more shares outstanding
  • The number of shares outstanding for NVX has been increased compared to 5 years ago.
  • NVX has a worse debt/assets ratio than last year.
NVX Yearly Shares OutstandingNVX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NVX Yearly Total Debt VS Total AssetsNVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • NVX has an Altman-Z score of -0.81. This is a bad value and indicates that NVX is not financially healthy and even has some risk of bankruptcy.
  • NVX has a worse Altman-Z score (-0.81) than 73.98% of its industry peers.
  • NVX has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
  • NVX's Debt to Equity ratio of 0.27 is in line compared to the rest of the industry. NVX outperforms 43.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z -0.81
ROIC/WACCN/A
WACC8.96%
NVX Yearly LT Debt VS Equity VS FCFNVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

  • NVX has a Current Ratio of 0.93. This is a bad value and indicates that NVX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NVX's Current ratio of 0.93 is on the low side compared to the rest of the industry. NVX is outperformed by 91.06% of its industry peers.
  • A Quick Ratio of 0.90 indicates that NVX may have some problems paying its short term obligations.
  • NVX has a worse Quick ratio (0.90) than 82.93% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.9
NVX Yearly Current Assets VS Current LiabilitesNVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The earnings per share for NVX have decreased strongly by -28.68% in the last year.
  • The Revenue for NVX has decreased by -24.01% in the past year. This is quite bad
  • NVX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.91% yearly.
EPS 1Y (TTM)-28.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.32%
Revenue 1Y (TTM)-24.01%
Revenue growth 3Y13.64%
Revenue growth 5Y20.91%
Sales Q2Q%-23.25%

3.2 Future

  • Based on estimates for the next years, NVX will show a very negative growth in Earnings Per Share. The EPS will decrease by -34.69% on average per year.
  • Based on estimates for the next years, NVX will show a very strong growth in Revenue. The Revenue will grow by 66.08% on average per year.
EPS Next Y26.19%
EPS Next 2Y20.27%
EPS Next 3Y21.99%
EPS Next 5Y-34.69%
Revenue Next Year2.09%
Revenue Next 2Y284.07%
Revenue Next 3Y204.67%
Revenue Next 5Y66.08%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NVX Yearly Revenue VS EstimatesNVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
NVX Yearly EPS VS EstimatesNVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NVX. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NVX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NVX Price Earnings VS Forward Price EarningsNVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NVX Per share dataNVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6

4.3 Compensation for Growth

  • NVX's earnings are expected to grow with 21.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.27%
EPS Next 3Y21.99%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for NVX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NOVONIX LTD-ADR

NASDAQ:NVX (2/11/2026, 4:30:02 PM)

After market: 0.93 0 (0%)

0.93

-0.01 (-1.59%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-20
Earnings (Next)02-26
Inst Owners12.08%
Inst Owner Change56.56%
Ins Owners2.68%
Ins Owner ChangeN/A
Market Cap195.32M
Revenue(TTM)5.93M
Net Income(TTM)-66.25M
Analysts84
Price Target1.43 (53.76%)
Short Float %1.97%
Short Ratio2.56
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-31.29%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 32.93
P/FCF N/A
P/OCF N/A
P/B 1.36
P/tB 1.48
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.28
Fwd EYN/A
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS0.03
BVpS0.68
TBVpS0.63
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -27.71%
ROE -46.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-22.59%
ROA(5y)-20.43%
ROE(3y)-33.39%
ROE(5y)-27.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 918.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.9
Altman-Z -0.81
F-Score2
WACC8.96%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)574.1%
Cap/Sales(5y)444.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.32%
EPS Next Y26.19%
EPS Next 2Y20.27%
EPS Next 3Y21.99%
EPS Next 5Y-34.69%
Revenue 1Y (TTM)-24.01%
Revenue growth 3Y13.64%
Revenue growth 5Y20.91%
Sales Q2Q%-23.25%
Revenue Next Year2.09%
Revenue Next 2Y284.07%
Revenue Next 3Y204.67%
Revenue Next 5Y66.08%
EBIT growth 1Y-1.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year22.7%
EBIT Next 3Y33.82%
EBIT Next 5Y13.32%
FCF growth 1Y-371.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-276.15%
OCF growth 3YN/A
OCF growth 5YN/A

NOVONIX LTD-ADR / NVX FAQ

What is the ChartMill fundamental rating of NOVONIX LTD-ADR (NVX) stock?

ChartMill assigns a fundamental rating of 2 / 10 to NVX.


Can you provide the valuation status for NOVONIX LTD-ADR?

ChartMill assigns a valuation rating of 1 / 10 to NOVONIX LTD-ADR (NVX). This can be considered as Overvalued.


How profitable is NOVONIX LTD-ADR (NVX) stock?

NOVONIX LTD-ADR (NVX) has a profitability rating of 0 / 10.


Can you provide the financial health for NVX stock?

The financial health rating of NOVONIX LTD-ADR (NVX) is 1 / 10.